A549 cells infected with SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
REL | hg19_v2_chr2_+_61108771_61108791 | 0.46 | 3.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_46546406 Show fit | 1.18 |
ENST00000440343.1
ENST00000415785.1 |
peroxisome proliferator-activated receptor alpha |
|
chr1_+_6845578 Show fit | 0.75 |
ENST00000467404.2
ENST00000439411.2 |
calmodulin binding transcription activator 1 |
|
chr19_+_58193388 Show fit | 0.61 |
ENST00000596085.1
ENST00000594684.1 |
zinc finger protein 551 Uncharacterized protein |
|
chr15_+_44719996 Show fit | 0.54 |
ENST00000559793.1
ENST00000558968.1 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2 |
|
chr17_-_15469590 Show fit | 0.53 |
ENST00000312127.2
|
CMT duplicated region transcript 1; Uncharacterized protein |
|
chr20_-_36156264 Show fit | 0.52 |
ENST00000445723.1
ENST00000414080.1 |
bladder cancer associated protein |
|
chr22_-_28490123 Show fit | 0.45 |
ENST00000442232.1
|
tetratricopeptide repeat domain 28 |
|
chr19_-_4338783 Show fit | 0.45 |
ENST00000601482.1
ENST00000600324.1 |
signal transducing adaptor family member 2 |
|
chr6_-_30080863 Show fit | 0.43 |
ENST00000540829.1
|
tripartite motif containing 31 |
|
chr4_-_185395191 Show fit | 0.42 |
ENST00000510814.1
ENST00000507523.1 ENST00000506230.1 |
interferon regulatory factor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.0 | 1.2 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 1.0 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.0 | 0.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.0 | 0.6 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.4 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.1 | 0.4 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
0.0 | 0.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.1 | 0.3 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.1 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.0 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.3 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.0 | 0.2 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.0 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.0 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.0 | 0.3 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.0 | 0.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.1 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 1.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 1.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 0.7 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 1.0 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.7 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |